Skip to main content

UBS Group AG

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in LENZ

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$635,165
-$801,284 QoQ
Shares Held
111,825
-28.8% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 143 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LENZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. LENZ ranks #281 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LENZ

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $635,165 111,825
2026-03-31 $1,436,449 156,989
2025-12-31 $25,147,808 1,571,738
2025-09-30 $55,971,272 1,201,616
2025-06-30 $25,836,207 881,481
2025-03-31 $17,152,785 667,164
2024-12-31 $2,480,741 85,928
2024-09-30 $145,881 6,145
2024-06-30 $70,231 4,062
2024-03-31 $95,369 4,271
2023-12-31 GRPH 30,712
2023-09-30 GRPH 15,653
2023-06-30 GRPH 19,953
2023-03-31 GRPH 8,967
2022-12-31 GRPH 1,526
2022-09-30 GRPH 1,526
2022-06-30 GRPH 48,222
2022-03-31 GRPH 5,289
2021-12-31 GRPH 7,881
2021-09-30 GRPH 2,509